Categoría: News
-
Adult Stem Cells Continue Going to the Dogs
Once again, the adult stem cell therapy pioneered by the veterinary company Vet-Stem comes to the rescue of man’s best friend.
-
Veterinary Stem Cell Therapies Translate into Human Therapies
Autologous adult stem cell therapies that are routinely used for the treatment of injuries and degenerative conditions in dogs and horses are now being translated into human clinical trials.
-
New NIH Stem Cell Guidelines are Slowing Research
The new Guidelines issued by NIH are seen by many embryonic stem cell scientists as an obstacle to research.
-
BioTime Receives Second Round of Funding
The embryonic stem cell company BioTime receives $4 million in its second equity tranche.
-
NIH received varied responses, some poignant, on stem-cell draft
There were approximately 49,000 comments sent into the NIH in response to a publicly available draft of the new guidelines to embryonic stem cell research.
-
New Technology Breakthroughs Showcased at Annual Stem Cell Conference
New advances in instrumentation and laboratory technology are featured at this year’s ISSCR conference in Barcelona.
-
BioTime Announces Agreement With Millipore
BioTime’s subsidiary, Embryome Sciences, enters into a co-marketing agreement with Millipore.
-
Cellular Dynamics Creates iPS Cells From Human Blood
Cellular Dynamics International announces a new breakthrough with iPS cells, having created the cells from human blood.
-
High School Coach Heads to Central America for Adult Stem Cell Therapy
Yet another American bravely decides to travel overseas for adult stem cell therapy that was pioneered by U.S. doctors but which is not available in the United States.
-
New Director of NIH Chosen
President Obama nominates the former director of The Human Genome Project, Dr. Francis Collins, as the new director of the National Institutes of Health.